Biomea Fusion, Inc.
6.46%
3,681,664
1840439
09077A106
Jun 19, 2025
Jul 22, 2025, 05:15 PM
Reporting Persons (6)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Chen Bihua | Individual | 6.46% | 3,681,664 | 110,792 | 3,570,872 |
| Cormorant Asset Management, LP | Partnership | 6.26% | 3,570,872 | 0 | 3,570,872 |
| Cormorant Global Healthcare Master Fund, LP | Partnership | 3.15% | 1,795,928 | 0 | 1,795,928 |
| Cormorant Global Healthcare GP, LLC | Other | 3.15% | 1,795,928 | 0 | 1,795,928 |
| Cormorant Private Healthcare Fund III LP | Partnership | 3.01% | 1,717,232 | 0 | 1,717,232 |
| Cormorant Private Healthcare GP III, LLC | Other | 3.01% | 1,717,232 | 0 | 1,717,232 |
Disclosure Items (3)
Common Stock
Biomea Fusion, Inc.
900 MIDDLEFIELD ROAD, REDWOOD CITY, CA, 94063
Cormorant Global Healthcare Master Fund, LP Cormorant Global Healthcare GP, LLC Cormorant Private Healthcare Fund III, LP Cormorant Private Healthcare GP III, LLC Cormorant Asset Management, LP Bihua Chen
200 Clarendon Street, 52nd Floor Boston, MA 02116
Cormorant Global Healthcare Master Fund, LP - Cayman Islands Cormorant Global Healthcare GP, LLC - Delaware Cormorant Private Healthcare Fund III, LP - Delaware Cormorant Private Healthcare GP III, LLC - Delaware Cormorant Asset Management, LP - Delaware Bihua Chen - United States
See Items 7-13 of the cover page and Item 2.
See Items 7-13 of the cover page and Item 2. The percentages reported herein with respect to the Reporting Persons' holdings are calculated based upon (i) a statement in a Prospectus filed by the Issuer on June 18, 2025 that there would be 57,022,250 shares of Common Stock outstanding following the closing of a public offering described therein, and (ii) a statement in a Current Report on Form 8-K filed by the Issuer on June 20, 2025 announcing that the public offering closed on that date. The shares reported for Bihua Chen reflect shares of Common Stock that she has the right to receive within 60 days upon the exercise of stock options granted to her in her capacity as a director of the Issuer.
The Reporting Persons did not engage in any transactions in securities of the Issuer during the sixty day period prior to the filing of this Schedule 13D.
Not applicable.
Not applicable.